Heart Disease News and Research

Latest Heart Disease News and Research

Healthy foods improve survival and quality of life in older adult population

In a study published in the January 2011 issue of the Journal of the American Dietetic Association, researchers investigated empirical data regarding the associations of dietary patterns with mortality through analysis of the eating patterns of over 2500 adults between the ages of 70 and 79 over a ten-year period.

22 Dec 2010

Altering balance among immune system cells could hold potential for T2D-associated inflammation treatment

Researchers from Boston University School of Medicine (BUSM) have demonstrated that certain T cells require input from monocytes in order to maintain their pro-inflammatory response in people with type 2 diabetes (T2D). The study also showed, for the first time, how a loss in homeostasis in this group of T cells most likely promotes chronic inflammation associated with T2D.

22 Dec 2010

Nature News explores developing countries' commitment to R&D

Nature News explores how a report published last week by the Organisation for Economic Co-operation and Development (OECD) documents the growing commitment of several developing countries to R&D (Casassus, 12/20).

22 Dec 2010

Pepex announces development of combined glucose monitoring and insulin delivery meter

Pepex Biomedical, Inc. has unveiled development of a next generation solution for insulin dependent diabetics which will combine regular glucose monitoring and insulin delivery for diabetes sufferers worldwide. The company is developing a complete product line of multi-function meters which allow simple testing of blood glucose levels and insulin delivery, appropriate to each glucose level measurement, all contained in a single, palm-sized unit. These meters provide anytime, anywhere tracking and treatment of diabetes.

22 Dec 2010

Moderately and morbidly obese drivers face increase risk of death during severe vehicle crashes

Moderately and morbidly obese persons face many health issues -- heart disease, diabetes, hypertension, stroke, gallbladder disease and others. Now, increased chances of dying while driving during a severe auto accident can be added to the list.

22 Dec 2010

Ontario hospital implants powerful new defibrillator

St. Michael's Hospital today became the first in Ontario to implant a small but powerful new defibrillator into a patient's chest.

22 Dec 2010

Verizon grants will eanble heart attack patients to receive life-saving treatments more quickly

Heart attack patients can receive life-saving treatments more quickly thanks to $100,000 in grants from the Verizon Foundation to the Foundation of UMDNJ for a program that enables heart attack patients to bypass the emergency room and go directly to the cardiac catheterization laboratory at UMDNJ-The University Hospital.

22 Dec 2010

Isis commences ISIS-APOCIIIRx Phase 1 trial in hypertriglyceridemia

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1 study of ISIS-APOCIIIRx, an antisense drug designed to lower triglycerides to treat a variety of diseases associated with elevated triglycerides. Hypertriglyceridemia, a condition characterized by elevated levels of triglycerides, is an independent risk factor for cardiovascular disease and is a component of numerous cardiovascular and metabolic diseases, including metabolic syndrome.

21 Dec 2010

Study on why whole orange is better than components

In time for Christmas, BYU nutritionists are squeezing all the healthy compounds out of oranges to find just the right mixture responsible for their age-old health benefits.

21 Dec 2010

Novel pen measures stress levels

In the future, more and more products will be able to interpret what users are feeling and use that information in a smart way. To illustrate the power of this theory, researcher Miguel Bruns Alonso has developed a pen which can measure the stress levels of the person using it, and can actually help to reduce that stress. In experiments, the heart rate of people who used the anti-stress pen fell by an average of five percent. On Wednesday, 23 December, Miguel Bruns Alonso will receive his PhD degree from TU Delft based on his research into this subject.

21 Dec 2010

LUMEDX announces subscription of 50 hospitals to cardiovascular SaaS solution

LUMEDX Corporation, a leading provider of vendor-neutral, integrated medical imaging and information systems, announced today that 50 hospitals now subscribe to its cardiovascular software-as-a-service (SaaS) solution. LUMEDX's SaaS delivery model allows clients to access and utilize software remotely via the web — resulting in faster implementations and lower licensing, maintenance and personnel costs. The service also includes built-in disaster recovery and high-intensity security systems.

21 Dec 2010

Cambridge Heart completes private placement

Cambridge Heart, Inc., developer of non-invasive diagnostic tests for cardiac disease, today announced that on December 20, 2010 it completed a private placement to accredited investors. The transaction raised gross proceeds of $2.9 million and consisted of Units that were comprised of one share of common stock and a warrant to purchase one share of common stock.

21 Dec 2010

Genzyme provides information on peak sale of alemtuzumab for multiple sclerosis

Genzyme Corporation today provided an extensive briefing on the market potential of alemtuzumab for multiple sclerosis at an event for investors and analysts in New York.

21 Dec 2010

Researchers present definitive explanation of how fibrotic cells destroy human liver

In the latest of a series of related papers, researchers at the University of California, San Diego School of Medicine, with colleagues in Austria and elsewhere, present a new and more definitive explanation of how fibrotic cells form, multiply and eventually destroy the human liver, resulting in cirrhosis. In doing so, the findings upend the standing of a long-presumed marker for multiple fibrotic diseases and reveal the existence of a previously unknown kind of inflammatory white blood cell.

21 Dec 2010

Group buy program helps hospitals save $81 million

Over the past year, 1,220 hospitals participating in the Premier healthcare alliance's group buy program have identified $81 million in savings through access to high-quality products at low costs.

21 Dec 2010

DNA sequence variations linked with heart's electrical rhythm in several surprising regions

A study among almost 50,000 people worldwide has identified DNA sequence variations linked with the heart's electrical rhythm in several surprising regions among 22 locations across the human genome. The variants were found by an international consortium, including Johns Hopkins researchers, and reported Nov. 14 in the Nature Genetics advance online publication.

21 Dec 2010

Magellan, ACG partner to train specialists to provide Peer Support Whole Health services

Magellan Health Services, Inc., an industry leader in behavioral health care management, and Appalachian Consulting Group (ACG) have joined forces to train peer specialists to provide Peer Support Whole Health (PSWH) services. PSWH, an evidence-based behavioral health practice that is growing in use across the country, focuses on improving the overall physical and mental health of individuals with mental illnesses to help them achieve their health and wellness goals.

21 Dec 2010

Silence provides year-end update on trading and offer-period

Silence Therapeutics plc, a leading global biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases, today provides a year-end update on trading and the offer-period.

21 Dec 2010

New research sheds light on complex regulatory pathways for effective innate immune system

New research by scientists at the University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences reveals that the immune system has an effective backup plan to protect the body from infection when the "master regulator" of the body's innate immune system fails.

21 Dec 2010

Scientists boost protein supply to enhance muscle function, reduce nerve-dependent fatigue in mice

Researchers at Vanderbilt University have "engineered" a mouse that can run on a treadmill twice as long as a normal mouse by increasing its supply of acetylcholine, the neurotransmitter essential for muscle contraction.

21 Dec 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Healthy foods improve survival and quality of life in older adult population

Altering balance among immune system cells could hold potential for T2D-associated inflammation treatment

Nature News explores developing countries' commitment to R&D

Pepex announces development of combined glucose monitoring and insulin delivery meter

Moderately and morbidly obese drivers face increase risk of death during severe vehicle crashes

Ontario hospital implants powerful new defibrillator

Verizon grants will eanble heart attack patients to receive life-saving treatments more quickly

Isis commences ISIS-APOCIIIRx Phase 1 trial in hypertriglyceridemia

Study on why whole orange is better than components

Novel pen measures stress levels

LUMEDX announces subscription of 50 hospitals to cardiovascular SaaS solution

Cambridge Heart completes private placement

Genzyme provides information on peak sale of alemtuzumab for multiple sclerosis

Researchers present definitive explanation of how fibrotic cells destroy human liver

Group buy program helps hospitals save $81 million

DNA sequence variations linked with heart's electrical rhythm in several surprising regions

Magellan, ACG partner to train specialists to provide Peer Support Whole Health services

Silence provides year-end update on trading and offer-period

New research sheds light on complex regulatory pathways for effective innate immune system

Scientists boost protein supply to enhance muscle function, reduce nerve-dependent fatigue in mice

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Heart Disease News and Research

Latest Heart Disease News and Research

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in